In drug development clinical pharmacology is tasked to ensure that patients receive the right dose at the right time. This ensures that the new medicine is safe and effective throughout the patient population. To achieve this goal, it is necessary to recognise the factors that can alter drug response. Knowledge of pharmacokinetics (PK) and pharmacokinetic/pharmacodynamic (PK/PD) relationships is at the heart of this endeavour. For many drugs, clinical pharmacology information accounts for almost 50% of the final drug label, further emphasising the importance of PK understanding in drug development.
The aim of this course is to provide participants with an overview of the principles of Pharmacokinetics and Pharmacokinetic/Pharmacodynamic modelling and how, together with regulatory guidances, they can be used to effectively deliver drug development programmes
What will participants gain-
鈥ncreased confidence to discuss PK issues within their drug projects
鈥nderstanding of the common PK terms and their importance
鈥nderstanding of how PK data influences the clinical development programme
鈥n understanding of the factors that contribute to variability in PK
鈥he role of PK/PD modelling in drug development
鈥n appreciation of how regulatory guidances influence PK
The aim of this course is to provide participants with an overview of the principles of Pharmacokinetics and Pharmacokinetic/Pharmacodynamic modelling and how, together with regulatory guidances, they can be used to effectively deliver drug development programmes
What will participants gain-
鈥ncreased confidence to discuss PK issues within their drug projects
鈥nderstanding of the common PK terms and their importance
鈥nderstanding of how PK data influences the clinical development programme
鈥n understanding of the factors that contribute to variability in PK
鈥he role of PK/PD modelling in drug development
鈥n appreciation of how regulatory guidances influence PK
